Viewing data from:

HYDROXYPROGESTERONE CAPROATE

ANDA

HYDROXYPROGESTERONE CAPROATE | A200271 | ASPEN GLOBAL INC

1 strength0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs5 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

ASPEN OSS BVHYDROXYPROGESTERONE CAPROATE

DMF 171132004

SUN PHARMACEUTICAL INDUSTRIES LTDHYDROXYPROGESTERONE CAPROATE USP

DMF 289582015

SYMBIOTEC PHARMALAB PRIVATE LTDHYDROXYPROGESTERONE CAPROATE USP

DMF 307472016

STEROID SPAHYDROXYPROGESTERONE CAPROATE

DMF 313372017

UPJOHN COInactiveHYDROXYPROGESTERONE CAPROATE

DMF 28561977

DIOSYNTH BVInactiveHYDROXYPROGESTERONE CAPROATE

DMF 29931977

DIOSYNTH BVInactiveHYDROXYPROGESTERONE CAPROATE

DMF 38451980

SCHERING AGInactiveHYDROXYPROGESTERONE CAPROATE

DMF 53181984

PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INCInactiveHYDROXYPROGESTERONE CAPROATE USP

DMF 325262018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 16, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 1250MG/5ML (250MG/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAMUSCULAR | Approved: Aug 24, 2015

No patent or exclusivity listings for this strength.